We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.52B
AUM Growth
+$98.3M
Cap. Flow
-$130M
Cap. Flow %
-3.71%
Top 10 Hldgs %
48.97%
Holding
139
New
23
Increased
31
Reduced
39
Closed
18

Top Buys

Rank Stock Value
1
MLKN icon
MillerKnoll
MLKN
+$61.9M
2
RDVT icon
Red Violet
RDVT
+$20.8M
3
PAYO icon
Payoneer
PAYO
+$19M
4
PWP icon
Perella Weinberg Partners
PWP
+$17.8M
5
IMAX icon
IMAX
IMAX
+$15.9M

Top Sells

Rank Stock Value
1
LNW
Light & Wonder
LNW
+$68M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$61.5M
3
CAR icon
Avis
CAR
+$43.1M
4
EHTH icon
eHealth
EHTH
+$20.4M
5
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 22.7%
2 Consumer Discretionary 7.81%
3 Technology 4.6%
4 Industrials 4.01%
5 Communication Services 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTY
76
CALL
DELISTED
Party City Holdco Inc.
PRTY
$9.33M 0.27%
+1,000,000
New +$8.16M
TSHA icon
77
Taysha Gene Therapies
TSHA
$1.86B
$9.16M 0.26%
432,072
+395,116
+1,069% +$9.11M
ZVO
78
DELISTED
Zovio Inc. Common Stock
ZVO
$8.14M 0.23%
3,141,286
+50,000
+2% +$153K
CAR icon
79
Avis
CAR
$4.96B
$8.03M 0.23%
103,100
-520,500
-83% -$43.1M
HCA icon
80
HCA Healthcare
HCA
$89.3B
$7.36M 0.21%
35,600
– –
ACAD icon
81
CALL
Acadia Pharmaceuticals
ACAD
$5.07B
$7.32M 0.21%
300,000
– –
RILY icon
82
BRC Group Holdings
RILY
$288M
$7.16M 0.2%
94,858
-6,674
-7% -$467K
SSKN
83
DELISTED
Strata Skin Sciences
SSKN
$7.15M 0.2%
458,391
– –
ZGNX
84
DELISTED
Zogenix, Inc.
ZGNX
$6.68M 0.19%
386,696
-86,359
-18% -$1.59M
HARP
85
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6.15M 0.17%
44,325
-956
-2% -$182K
DVD
86
DELISTED
Dover Motorsports
DVD
$5.84M 0.17%
2,597,086
– –
XGN icon
87
Exagen
XGN
$160M
$5.51M 0.16%
367,936
-6,379
-2% -$97.8K
RGS icon
88
PUT
Regis Corp
RGS
$70.8M
$5.15M 0.15%
27,500
+7,500
+38% +$1.6M
IMA
89
ImageneBio Inc
IMA
$62.5M
$4.91M 0.14%
29,138
+2,055
+8% +$453K
BACK
90
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$4.9M 0.14%
82,455
-878
-1% -$48.3K
HOOK
91
DELISTED
HOOKIPA Pharma
HOOK
$4.69M 0.13%
51,211
-38,789
-43% -$5.17M
ELOX
92
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$4.51M 0.13%
+56,657
New +$4.73M
ARYD
93
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$4.29M 0.12%
400,000
– –
LVTX
94
DELISTED
LAVA Therapeutics
LVTX
$4.15M 0.12%
381,227
– –
ROCRU
95
DELISTED
Roth CH Acquisition III Co. Unit
ROCRU
$4.11M 0.12%
399,006
-994
-0.2% -$9.98K
BRPMU
96
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
$3.8M 0.11%
375,000
– –
MACK
97
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.65M 0.1%
571,946
-37,028
-6% -$244K
TFFP
98
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$3.54M 0.1%
14,713
-589
-4% -$162K
NPCE icon
99
Neuropace
NPCE
$502M
$3.51M 0.1%
+147,404
New +$3.42M
HCAQ
100
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$3.49M 0.1%
354,296
+63,700
+22% +$630K
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Nantahala Capital Management held 139 positions worth $3.52B, up 2.9% from $3.42B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Nantahala Capital Management withdrew a net $130M in Q2 2021, closing 18 positions and reducing 39 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $61.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Nantahala Capital Management opened a new position in MillerKnoll worth $64.4M.

  • Nantahala Capital Management's largest Q2 2021 buy was MillerKnoll: 1,366,266 shares worth $64.4M.
  • Nantahala Capital Management added most to IMAX in Q2 2021, an estimated $15.9M increase.
  • Nantahala Capital Management's biggest Q2 2021 reduction was Light & Wonder, cutting an estimated $68M.
  • Nantahala Capital Management fully exited iShares Russell 2000 ETF in Q2 2021, selling an estimated $61.5M.
  • Nantahala Capital Management's ten largest holdings make up 49% of its $3.52B portfolio in Q2 2021.
  • Nantahala Capital Management opened 23 new positions and closed 18 in Q2 2021.
  • Nantahala Capital Management's portfolio value rose 2.9% quarter-over-quarter to $3.52B.

Based on Nantahala Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.